Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This is resulting in a decline in the company's revenues.

Align Technology Stock Dips on Macroeconomic Issues, FX Headwind

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align T.

Align Technology to Speak at Upcoming Financial Conference

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced leadership updates for the Asia Pacific, Americas, and EMEA regions. Medical technology industry executive David Carr has joined Align as EVP and MD of the Asia Pacific region. Raj Pudi.

Align Technology Announces New Regional Leadership Roles

Align Technology , the maker of Invisalign clear teeth aligners, agreed to pay $27.5 million to settle a lawsuit claiming it entered an illegal antitrust conspiracy that drove up prices of aligners made by rival SmileDirectClub.

Invisalign maker reaches $27.5 million settlement of consumer antitrust lawsuit

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Align Technology (ALGN) Up 1.2% Since Last Earnings Report: Can It Continue?

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, today announced it is piloting a new U.S. Invisalign treatment promotional program for Costco members on Costco.com. An Invisalign treatment e-card and Invisalign™ Essentials Bundle+ is now available for Costco membe.

Align Technology Pilots U.S. Invisalign® Treatment Promotional Program on Costco.com

Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Columbia Digital Dentistry Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Dental CAD/CAM Devices, Dental CAD/CAM Materials (Discs & Blocks), Dental 3D Printers, and 2 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the Colombian digital dentistry market was valued at nearly $14.3 million. It is expected to grow at a CAGR of 3.8%, reaching over $18.6 million by the end of the forecast period. The comprehensive report on the Colombian market for digital dentistry covers various segments, including computer-aided design/computer-aided manufacturing (CAD/CAM) devices, CAD/CAM materials, dental 3D printers, dental 3D printer materials, and CAD/CAM software. Currently, the majority of Colombia's digital dentistry market share is controlled by Dentsply Sirona, Ivoclar Vivadent, and 3D Systems.

Columbia Digital Dentistry Market Size, Share & Trends Analysis 2024-2030 Featuring Align Technology, Dentsply, and Sirona Medit

Align's recent earnings were underwhelming, leading to a 21.56% YTD stock drop. Q2 2024 earnings showed mixed results, with EPS beating estimates but revenue slightly lower than expected. Align's potential lies in its large TAM, strong gross margin, and top management, but growth needs to accelerate for investor trust.

Align Technology: Mixed Earnings Sparks Sell-Off

Align Technology's (ALGN) Clear Aligner ASP is facing a significant impact of unfavorable foreign exchange across multiple currencies.

Align Technology (ALGN) Encounters Low ASP, FX Headwinds

Non-GAAP EPS rose 8.6% year over year to $2.41 per share. Total revenue was $1,028.5 million, an increase of 2.6%.

Align Technology EPS Rises in Q2 2024

Align Technology's (ALGN) records second-quarter 2024 revenue growth across all regions. This was mostly due to a robust performance by the Imaging Systems & CAD/CAM Services business segment.

Align Technology (ALGN) Beats on Q2 Earnings, Lowers '24 Sales View

Align Technology, Inc. (NASDAQ:ALGN ) Q2 2024 Earnings Conference Call July 24, 2024 4:30 PM ET Company Participants Shirley Stacy - Vice President of Corporate Communications & Investor Relations Joe Hogan - President & Chief Executive Officer John Morici - Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Jonathan Block - Stifel, Nicolaus & Company Jeff Johnson - Baird Brandon Vazquez - William Blair Jason Bednar - Piper Sandler Michael Ryskin - Bank of America Erin Wright - Morgan Stanley Operator Greetings. Welcome to the Align Technology Second Quarter 2024 Earnings Call.

Align Technology, Inc. (ALGN) Q2 2024 Earnings Call Transcript

The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Align Technology (ALGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Align Technology (ALGN) came out with quarterly earnings of $2.41 per share, beating the Zacks Consensus Estimate of $2.32 per share. This compares to earnings of $2.22 per share a year ago.

Align Technology (ALGN) Q2 Earnings Top Estimates

Shares of Align Technology Inc. fell more than 9% in the extended session Wednesday after the maker of Invisalign and other orthodontic devices saw lower prices for its clear braces and dialed down its expectations for revenue growth this year, saying consumers shifted to cheaper offerings.

Invisalign's maker says consumers downshifted to lower-priced clear braces

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("Q2'24"). Q2'24 total revenues were $1,028.5 million, up 3.1% sequentially and up 2.6% year-over-year. Q2'24 total revenues were unfavorably imp.

Align Technology Announces Second Quarter 2024 Financial Results

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, today introduced the iTero™ Design Suite, offering doctors an intuitive way to facilitate designs for 3D printing of models, bite splints, and restorations in-practice. The latest software innovation is designed to h.

Align Technology Introduces iTero™ Design Suite, Enabling Intuitive Design Capabilities for In-Practice 3D Printing to Boost Practice Efficiency

Boston Scientific

Edwards Lifesciences

Thermo Fisher Scientific

Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.

Can These 4 MedTech Stocks Hit Targets This Earnings Season?

Align Technology's (ALGN) second-quarter results are likely to reflect the strength in its Clear Aligner and Systems & Services businesses.

Will Clear Aligner Sales Drive Align Technology's (ALGN) Q2 Earnings?

Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Align Technology (ALGN) Earnings Expected to Grow: Should You Buy?

Announcement reflects Align Technology's continued partnership in Operation Smile's commitment to youth development through education, service, and leadership opportunities VIRGINIA BEACH, Va. and TEMPE, Ariz.

Operation Smile Announces Align Technology as Title Sponsor of International Student Leadership Conference

Align Technology reported its Q1 FY24 earnings and is due to report Q2 earnings on June 24th where revenue is expected to grow 4% YoY with non-GAAP operating margin slightly increasing sequentially. With Q1 revenue off to a stronger than expected start on shipments and higher ASPs across Clear Aligner and Systems and Services Segment, management raised their revenue guidance. However, Hedgeye has recently added Align to its short list with a possible 20% downside from weaker Q2, as well as lower forecast for H2 and beyond from macroeconomic pressures.

Align Technology: The Short-Sellers Are Wrong

Align Technology's (ALGN) Invisalign portfolio expansion efforts spark optimism.

Here's Why Holding Align Technology (ALGN) Stock Could Pay Off

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2024 financial results on Wednesday, July 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and w.

Align Technology to Announce Second Quarter 2024 Results on July 24, 2024

Align Technology Inc (NASDAQ: ALGN) is keeping in the green at writing even after Hedgeye named it a new short idea on Friday.  Shares of the 3D digital scanners company are down more than 20% versus their year-to-date high.

News for Align Technology Stock (ALGN)